Citi Discount Zert NKE 26.06.2024/ DE000KH5Y9A6 /
13/05/2024 12:43:24 | Var.+0.070 | Denaro13:06:59 | Lettera- | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
83.450EUR | +0.08% | 83.350 Quantità in denaro: 2,000 |
- Quantità in lettera: - |
NIKE INC. B | - - | 26/06/2024 | Call |
GlobeNewswire
13:00
Entera Bio to Present Phase 1 Data from First-in-Class, PTH(1-34) Peptide Tablets (EB612) for the Tr...
GlobeNewswire
13:00
Autolus Therapeutics Announces Delay to its First Quarter 2024 Earnings Release and Conference Call
GlobeNewswire
13:00
Bitfarms Announces Acceleration of Previously Announced Termination of CEO and Provides Update on Ne...
GlobeNewswire
13:00
Tiziana Life Sciences Files for Orphan Drug Designation for Intranasal Foralumab
GlobeNewswire
13:00
Lilium in advanced discussions with French government to expand industrial footprint with high-volum...
GlobeNewswire
13:00
Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...
GlobeNewswire
13:00
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 20...
GlobeNewswire
13:00
Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
GlobeNewswire
13:00
Village Farms International Appoints Finance and Operations Veteran Carolyn Hauger to Board
GlobeNewswire
13:00
Walden Biosciences Announces Research Collaboration with World Renowned Genetic Epidemiologist to Ad...
GlobeNewswire
13:00
Lantronix Inc. Appoints Mathi Gurusamy as Chief Strategy Officer to Drive Strategic Growth and Build...
GlobeNewswire
13:00
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2024 Financial Result...
GlobeNewswire
13:00
TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
13:00
Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates